Activist Clinton Group Targets Xenoport

Activist Clinton Group Targets Xenoport Play

Oct. 16 (Bloomberg) -- XenoPort should shift spending to an experimental multiple sclerosis treatment and replace its chief executive officer, shareholder Clinton Group said in a letter to management. Clinton Group President Gregory Taxin speaks with Erik Schatzker on Bloomberg Television's "Market Makers." (Source: Bloomberg)

  • On Air Now

    Charlie Rose Watch Now

  • Next

    Taking Stock with Pimm Fox

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus